TGF-β and NF-κB signal pathway cross-talk is mediated through TAK1 and SMAD7 in a subset of head and neck cancers.

MLA

Freudlsperger, C., et al. “TGF-β and NF-ΚB Signal Pathway Cross-Talk Is Mediated through TAK1 and SMAD7 in a Subset of Head and Neck Cancers.” Oncogene, vol. 32, no. 12, Mar. 2013, pp. 1549–59. EBSCOhost, https://doi.org/10.1038/onc.2012.171.

APA

Freudlsperger, C., Bian, Y., Contag Wise, S., Burnett, J., Coupar, J., Yang, X., Chen, Z., & Van Waes, C. (2013). TGF-β and NF-κB signal pathway cross-talk is mediated through TAK1 and SMAD7 in a subset of head and neck cancers. Oncogene, 32(12), 1549–1559. https://doi.org/10.1038/onc.2012.171

Chicago

Freudlsperger, C, Y Bian, S Contag Wise, J Burnett, J Coupar, X Yang, Z Chen, and C Van Waes. 2013. “TGF-β and NF-ΚB Signal Pathway Cross-Talk Is Mediated through TAK1 and SMAD7 in a Subset of Head and Neck Cancers.” Oncogene 32 (12): 1549–59. doi:10.1038/onc.2012.171.